An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

Roman‐Ulrich Müller, Stephen B. Walsh and Ron T. Gansevoort, Henrik Birn et al.|KIDNEYS|2022

Cited by 6